Based on above results and given that the GRK2/PI3K-AKT pathway contributes to the regulation of immune cell metabolism (Yang et al., 2020), we speculated that inhibiting the over activated PI3K-AKT pathway in immune cells might be effective methods for the treatment of RA and other autoimmune diseases such as AIH. The gene discussed is AKT1; the disease is autoimmune hepatitis.